Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567008 · ClinicalTrials.gov registry record · Phase 2
Chantix for Treating Cocaine Dependence
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
NCT00567008: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00567008 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 37 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00567008, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether varenicline (Chantix), is effective for the treatment of cocaine dependence.
Interventions
- DRUG placebo
- DRUG varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567008
The ClinicalTrials.gov registry entry for NCT00567008 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00567008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567008 about?
NCT00567008 is a clinical study titled "Chantix for Treating Cocaine Dependence". The purpose of this study is to determine whether varenicline (Chantix), is effective for the treatment of cocaine dependence.
What is the current status of trial NCT00567008?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2007-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00567008?
The interventions under investigation include: placebo (DRUG), varenicline (DRUG).
Who is sponsoring clinical trial NCT00567008?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.